Undiagnosed symptomatic primary HIV infections in South London. 2001

M Melzer, and M Brown, and J Mullen, and S O'Shea, and I Chrystie, and J Banatvala

UI MeSH Term Description Entries
D008131 London The capital of the United Kingdom. It is located in England.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003955 Diagnostic Tests, Routine Diagnostic procedures, such as laboratory tests and x-rays, routinely performed on all individuals or specified categories of individuals in a specified situation, e.g., patients being admitted to the hospital. These include routine tests administered to neonates. Admission Tests, Routine,Hospital Admission Tests,Physical Examination, Preadmission,Routine Diagnostic Tests,Admission Tests, Hospital,Diagnostic Test, Routine,Diagnostic Tests,Examination, Preadmission Physical,Preadmission Physical Examination,Routine Diagnostic Test,Test, Routine Diagnostic,Tests, Diagnostic,Tests, Hospital Admission,Tests, Routine Diagnostic,Admission Test, Hospital,Admission Test, Routine,Diagnostic Test,Examinations, Preadmission Physical,Hospital Admission Test,Physical Examinations, Preadmission,Preadmission Physical Examinations,Routine Admission Test,Routine Admission Tests,Test, Diagnostic,Test, Hospital Admission,Test, Routine Admission,Tests, Routine Admission
D005260 Female Females
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated

Related Publications

M Melzer, and M Brown, and J Mullen, and S O'Shea, and I Chrystie, and J Banatvala
May 2020, International journal of STD & AIDS,
M Melzer, and M Brown, and J Mullen, and S O'Shea, and I Chrystie, and J Banatvala
November 2012, Scandinavian journal of infectious diseases,
M Melzer, and M Brown, and J Mullen, and S O'Shea, and I Chrystie, and J Banatvala
December 1995, Lancet (London, England),
M Melzer, and M Brown, and J Mullen, and S O'Shea, and I Chrystie, and J Banatvala
April 1992, Lancet (London, England),
M Melzer, and M Brown, and J Mullen, and S O'Shea, and I Chrystie, and J Banatvala
January 2018, JAMA,
M Melzer, and M Brown, and J Mullen, and S O'Shea, and I Chrystie, and J Banatvala
March 1993, Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde,
M Melzer, and M Brown, and J Mullen, and S O'Shea, and I Chrystie, and J Banatvala
August 2022, BMC infectious diseases,
M Melzer, and M Brown, and J Mullen, and S O'Shea, and I Chrystie, and J Banatvala
March 1990, Lancet (London, England),
M Melzer, and M Brown, and J Mullen, and S O'Shea, and I Chrystie, and J Banatvala
December 2022, BMJ open quality,
M Melzer, and M Brown, and J Mullen, and S O'Shea, and I Chrystie, and J Banatvala
November 2009, International journal of STD & AIDS,
Copied contents to your clipboard!